The Role of the Complexed-to-Total Prostate-Specific Antigen Ratio in Predicting the Final Pathological Stage of Clinically Localized Prostate Cancer

By Martnez M.   Navarro S.   Medina P.   Villavicencio H.   Rioja L.   Solsona E.   Estelles A.   Aznar J.   Jimenez-Cruz J.F.   Espana F.  

European Urology, Vol. 43, Iss. 6, 2003-06 ,pp. : 609-614

Elsevier

Access to resources Recommend Favorite

Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy

By Potter S.R.   Miller M.C.   Mangold L.A.   Jones K.A.   Epstein J.I.   Veltri R.W.   Partin A.W.  

Urology, Vol. 54, Iss. 5, 1999-11 ,pp. : 791-795

Elsevier

Access to resources Recommend Favorite

Metallothionein expression in renal cancer - correlation with Gleason grade, pathological stage, DNA content and serum level of prostate specific antigen

By Izawa J.I.   Moussa M.   Cherian M.G.   Doig G.   Chin J.L.  

Urology, Vol. 52, Iss. 5, 1998-11 ,pp. : 767-772

Elsevier

Access to resources Recommend Favorite

Long-term results of pathological stage I non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control

By Wu Y.-C.   Lin C.-F.J.   Hsu W.-H.   Huang B.-S.   Huang M.-H.   Wang L.-S.  

European Journal of Cardio-Thoracic Surgery, Vol. 24, Iss. 6, 2003-12 ,pp. : 994-1001

Elsevier

Access to resources Recommend Favorite

Predicting the outcome of prostate biopsy in a racially diverse population: a prospective study

By Porter C.R.   O'Donnell C.   Crawford E.D.   Gamito E.J.   Sentizimary B.   De Rosalia A.   Tewari A.  

Urology, Vol. 60, Iss. 5, 2002-11 ,pp. : 831-835

Elsevier

Access to resources Recommend Favorite